|
1
|
Obrador E, Salvador R, Villaescusa JI,
Soriano JM, Estrela JM and Montoro A: Radioprotection and
radiomitigation: From the bench to clinical practice. Biomedicines.
8:4612020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mishra K and Alsbeih G: Appraisal of
biochemical classes of radioprotectors: Evidence, current status
and guidelines for future development. 3 Biotech. 7:2922017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Wang X, Miao L, Guo Y, Yuan R, Ren
J, Huang Y and Tian H: Design, synthesis, and biological evaluation
of a novel aminothiol compound as potential radioprotector. Oxid
Med Cell Longev. 2021:47146492021.PubMed/NCBI
|
|
4
|
Mishra KN, Moftah BA and Alsbeih GA:
Appraisal of mechanisms of radioprotection and therapeutic
approaches of radiation countermeasures. Biomed Pharmacother.
106:610–617. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Bi K, Yang R, Li H, Nikitaki Z and
Chang L: Role of DNA damage and repair in radiation cancer therapy:
A current update and a look to the future. Int J Radiat Biol.
96:1329–1338. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santivasi WL and Xia F: Ionizing
radiation-induced DNA damage, response, and repair. Antioxid Redox
Signal. 21:251–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao L, Bao C, Shang Y, He X, Ma C, Lei X,
Mi D and Sun Y: The determinant of DNA repair pathway choices in
ionising radiation-induced DNA double-strand breaks. Biomed Res
Int. 2020:48349652020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao M, Rogers L, Suchowerska N, Choe D,
Al-Dabbas MA, Narula RS, Lyons JG, Sved P, Li Z and Dong Q:
Sensitization of prostate cancer to radiation therapy: Molecules
and pathways to target. Radiother Oncol. 128:283–300. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kavanagh JN, Redmond KM, Schettino G and
Prise KM: DNA double strand break repair: A radiation perspective.
Antioxid Redox Signal. 18:2458–2472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang RX and Zhou PK: DNA damage response
signaling pathways and targets for radiotherapy sensitization in
cancer. Signal Transduct Target Ther. 5:602020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allegra AG, Mannino F, Innao V, Musolino C
and Allegra A: Radioprotective agents and enhancers factors.
Preventive and therapeutic strategies for oxidative induced
radiotherapy damages in hematological malignancies. Antioxidants
(Basel). 9:11162020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalman NS, Zhao SS, Anscher MS and
Urdaneta AI: Current status of targeted radioprotection and
radiation injury mitigation and treatment agents: A critical review
of the literature. Int J Radiat Oncol Biol Phys. 98:662–682. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deas SD, Huprikar N and Skabelund A:
Radiation exposure and lung disease in today's nuclear world. Curr
Opin Pulm Med. 23:167–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gudkov SV, Popova NR and Bruskov VI:
Radioprotectors: History, trends and prospects. Biofizika.
60:801–811. 2015.(In Russian). PubMed/NCBI
|
|
15
|
Singh VK and Seed TM: Pharmacological
management of ionizing radiation injuries: Current and prospective
agents and targeted organ systems. Expert Opin Pharmacother.
21:317–337. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patyar RR and Patyar S: Role of drugs in
the prevention and amelioration of radiation induced toxic effects.
Eur J Pharmacol. 819:207–216. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mun GI, Kim S, Choi E, Kim CS and Lee YS:
Correction to: Pharmacology of natural radioprotectors. Arch Pharm
Res. 43:272–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheema AK, Li Y, Girgis M, Jayatilake M,
Fatanmi OO, Wise SY, Seed TM and Singh VK: Alterations in tissue
metabolite profiles with amifostine-prophylaxed mice exposed to
gamma radiation. Metabolites. 10:2112020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
King M, Joseph S, Albert A, Thomas TV,
Nittala MR, Woods WC, Vijayakumar S and Packianathan S: Use of
amifostine for cytoprotection during radiation therapy: A review.
Oncology. 98:61–80. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barbosa SCM, Pereira VBM, Wong DVT,
Santana APM, Lucetti LT, Carvalho LL, Barbosa CRN, Callado RB,
Silva CAA, Lopes CDH, et al: Amifostine reduces inflammation and
protects against 5-fluorouracil-induced oral mucositis and
hyposalivation. Braz J Med Biol Res. 52:e82512019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang H, Yi W, Wang X, Tao Y, Yang X, Chen
C, Zhang W, Zhou S, Liu S, Li X, et al: Effectiveness and safety of
different amifostine regimens: Preliminary results of a phase II
multicenter randomized controlled trial. Chin J Cancer Res.
30:307–314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferraiolo DM and Veitz-Keenan A:
Insufficient evidence for interventions to prevent dry mouth and
salivary gland dysfunction post head and neck radiotherapy. Evid
Based Dent. 19:30–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim JM, Kim JW, Choi ME, Kim SK, Kim YM
and Choi JS: Protective effects of curcumin on radioiodine-induced
salivary gland dysfunction in mice. J Tissue Eng Regen Med.
13:674–681. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma SJ, Rivers CI, Serra LM and Singh AK:
Long-term outcomes of interventions for radiation-induced
xerostomia: A review. World J Clin Oncol. 10:1–13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riley P, Glenny AM, Hua F and Worthington
HV: Pharmacological interventions for preventing dry mouth and
salivary gland dysfunction following radiotherapy. Cochrane
Database Syst Rev. 7:CD0127442017.PubMed/NCBI
|
|
26
|
Torun N, Muratli A, Serim BD, Ergulen A
and Altun GD: Radioprotective effects of amifostine, L-carnitine
and vitamin e in preventing early salivary gland injury due to
radioactive iodine treatment. Curr Med Imaging Rev. 15:395–404.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luby AO, Subramanian C, Buchman LK, Lynn
JV, Urlaub KM, Nelson NS, Donneys A, Cohen MS and Buchman SR:
Amifostine prophylaxis in irradiated breast reconstruction: A study
of oncologic safety in vitro. Ann Plast Surg. 85:424–429. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Molkentine JM, Fujimoto TN, Horvath TD,
Grossberg AJ, Garcia CJG, Deorukhkar A, de la Cruz Bonilla M, Lin
D, Samuel ELG, Chan WK, et al: Enteral activation of WR-2721
mediates radioprotection and improved survival from lethal
fractionated radiation. Sci Rep. 9:19492019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu X, Li M, Zhu L, Li J, Zhang G, Fang R,
Wu Z and Jin Y: Amifostine-loaded armored dissolving microneedles
for long-term prevention of ionizing radiation-induced injury. Acta
Biomater. 112:87–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh VK and Seed TM: The efficacy and
safety of amifostine for the acute radiation syndrome. Expert Opin
Drug Saf. 18:1077–1090. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang D, Zhong D, Ouyang J, He J, Qi Y,
Chen W, Zhang X, Tao W and Zhou M: Microalgae-based oral
microcarriers for gut microbiota homeostasis and intestinal
protection in cancer radiotherapy. Nat Commun. 13:14132022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Daugėlaitė G, Užkuraitytė K, Jagelavičienė
E and Filipauskas A: Prevention and treatment of chemotherapy and
radiotherapy induced oral mucositis. Medicina (Kaunas). 55:252019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Epstein JB, Silverman S Jr, Paggiarino DA,
Crockett S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ,
Peterson DE and Leveque FG: Benzydamine HCl for prophylaxis of
radiation-induced oral mucositis: Results from a multicenter,
randomized, double-blind, placebo-controlled clinical trial.
Cancer. 92:875–885. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nicolatou-Galitis O, Bossi P, Orlandi E
and Bensadoun RJ: The role of benzydamine in prevention and
treatment of chemoradiotherapy-induced mucositis. Support Care
Cancer. 29:5701–5709. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Manoharan V, Fareed N, Battur H, Khanagar
S and Praveena J: Effectiveness of mouthrinses in prevention and
treatment of radiation induced mucositis: A systematic review. J
Cancer Res Ther. 16 (Suppl):S1–S10. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu YT, Deng JL, Jin XR, Zhang ZZ, Zhang XH
and Zhou X: Effects of 9 oral care solutions on the prevention of
oral mucositis: A network meta-analysis of randomized controlled
trials. Medicine (Baltimore). 99:e196612020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chitapanarux I, Tungkasamit T, Petsuksiri
J, Kannarunimit D, Katanyoo K, Chakkabat C, Setakornnukul J,
Wongsrita S, Jirawatwarakul N, Lertbusayanukul C, et al: Randomized
control trial of benzydamine HCl versus sodium bicarbonate for
prophylaxis of concurrent chemoradiation-induced oral mucositis.
Support Care Cancer. 26:879–886. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kakoei S, Pardakhty A, Hashemipour MA,
Larizadeh H, Kalantari B and Tahmasebi E: Comparison the pain
relief of amitriptyline mouthwash with benzydamine in oral
mucositis. J Dent (Shiraz). 19:34–40. 2018.PubMed/NCBI
|
|
39
|
Papanikolopoulou A, Syrigos N, Vini L,
Papasavva M, Lazopoulos G, Kteniadakis S, Spandidos DA, Charpidou A
and Drakoulis N: Use of oral glutamine in radiation-induced adverse
effects in patients with thoracic and upper aerodigestive
malignancies: Results of a prospective observational study. Oncol
Lett. 23:192022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang SC, Lai YC, Hung JC and Chang CY:
Oral glutamine supplements reduce concurrent
chemoradiotherapy-induced esophagitis in patients with advanced
non-small cell lung cancer. Medicine (Baltimore). 98:e144632019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao DD, Xu HL, Xu M, Qian XY, Yin ZC and
Ge W: Therapeutic role of glutamine in management of radiation
enteritis: A meta-analysis of 13 randomized controlled trials.
Oncotarget. 8:30595–30605. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vidal-Casariego A, Calleja-Fernández A, de
Urbina-González JJ, Cano-Rodríguez I, Cordido F and
Ballesteros-Pomar MD: Efficacy of glutamine in the prevention of
acute radiation enteritis: A randomized controlled trial. JPEN J
Parenter Enteral Nutr. 38:205–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vidal-Casariego A, Calleja-Fernández A,
Cano-Rodríguez I, Cordido F and Ballesteros-Pomar MD: Effects of
oral glutamine during abdominal radiotherapy on chronic radiation
enteritis: A randomized controlled trial. Nutrition. 31:200–204.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Erbil Y, Oztezcan S, Giriş M, Barbaros U,
Olgaç V, Bilge H, Küçücük H and Toker G: The effect of glutamine on
radiation-induced organ damage. Life Sci. 78:376–382. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ersin S, Tuncyurek P, Esassolak M, Alkanat
M, Buke C, Yilmaz M, Telefoncu A and Kose T: The prophylactic and
therapeutic effects of glutamine- and arginine-enriched diets on
radiation-induced enteritis in rats. J Surg Res. 89:121–125. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Alshawa A, Cadena AP, Stephen B, Reddy A,
Mendoza TR, McQuinn L, Lawhorn K, Zarifa A, Bernhardt AM, Fessaheye
S, et al: Effects of glutamine for prevention of radiation-induced
esophagitis: A double-blind placebo-controlled trial. Invest New
Drugs. 39:1113–1122. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Topkan E, Yavuz MN, Onal C and Yavuz AA:
Prevention of acute radiation-induced esophagitis with glutamine in
non-small cell lung cancer patients treated with radiotherapy:
Evaluation of clinical and dosimetric parameters. Lung Cancer.
63:393–399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vidal-Casariego A, Calleja-Fernández A,
Ballesteros-Pomar MD and Cano-Rodríguez I: Efficacy of glutamine in
the prevention of oral mucositis and acute radiation-induced
esophagitis: A retrospective study. Nutr Cancer. 65:424–429. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rubio I, Suva LJ, Todorova V,
Bhattacharyya S, Kaufmann Y, Maners A, Smith M and Klimberg VS:
Oral glutamine reduces radiation morbidity in breast conservation
surgery. JPEN J Parenter Enteral Nutr. 37:623–630. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yavas C, Yavas G, Celik E, Buyukyoruk A,
Buyukyoruk C, Yuce D and Ata O: Beta-hydroxy-beta-methyl-butyrate,
L-glutamine, and L-arginine supplementation improves
radiation-induce acute intestinal toxicity. J Diet Suppl.
16:576–591. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Setiadi A, Korim WS, May CN and Yao ST:
Systemic administration of pentoxifylline attenuates the
development of hypertension in renovascular hypertensive rats.
Hypertens Res. 43:667–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hendawy N: Pentoxifylline attenuates
cytokine stress and Fas system in syngeneic liver proteins induced
experimental autoimmune hepatitis. Biomed Pharmacother. 92:316–323.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Seirafianpour F, Mozafarpoor S, Fattahi N,
Sadeghzadeh-Bazargan A, Hanifiha M and Goodarzi A: Treatment of
COVID-19 with pentoxifylline: Could it be a potential adjuvant
therapy? Dermatol Ther. 33:e137332020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang K and Tepper JE: Radiation
therapy-associated toxicity: Etiology, management, and prevention.
CA Cancer J Clin. 71:437–454. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Price ML, Lai YE, Marcus KL, Robertson JB,
Lascelles BDX and Nolan MW: Early radiation-induced oral pain
signaling responses are reduced with pentoxifylline treatment. Vet
Radiol Ultrasound. 62:255–263. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Andreyev HJN, Matthews J, Adams C, Gothard
L, Lucy C, Tovey H, Boyle S, Anbalagan S, Musallam A, Yarnold J, et
al: Randomised single centre double-blind placebo controlled phase
II trial of Tocovid SupraBio in combination with pentoxifylline in
patients suffering long-term gastrointestinal adverse effects of
radiotherapy for pelvic cancer: The PPALM study. Radiother Oncol.
168:130–137. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pedro-Botet J and Pintó X:
LDL-cholesterol: The lower the better. Clin Investig Arterioscler.
31 (Suppl 2):S16–S27. 2019.PubMed/NCBI
|
|
58
|
Lee MS, Liu DW, Hung SK, Yu CC, Chi CL,
Chiou WY, Chen LC, Lin RI, Huang LW, Chew CH, et al: Emerging
challenges of radiation-associated cardiovascular dysfunction
(RACVD) in modern radiation oncology: Clinical practice, bench
investigation, and multidisciplinary care. Front Cardiovasc Med.
7:162020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Moon SH, Huang CH, Houlihan SL, Regunath
K, Freed-Pastor WA, Morris JP IV, Tschaharganeh DF, Kastenhuber ER,
Barsotti AM, Culp-Hill R, et al: p53 represses the mevalonate
pathway to mediate tumor suppression. Cell. 176:564–580.e19. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li P, Liu X, Zhao T, Li F, Wang Q, Zhang
P, Hirayama R, Chen W, Jin X, Zheng X, et al: Comparable radiation
sensitivity in p53 wild-type and p53 deficient tumor cells
associated with different cell death modalities. Cell Death Discov.
7:1842021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kwak SY, Park S, Kim H, Lee SJ, Jang WS,
Kim MJ, Lee S, Jang WI, Kim AR, Kim EH, et al: Atorvastatin
inhibits endothelial PAI-1-mediated monocyte migration and
alleviates radiation-induced enteropathy. Int J Mol Sci.
22:18282021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Pathak R, Kumar VP, Hauer-Jensen M and
Ghosh SP: Enhanced survival in mice exposed to ionizing radiation
by combination of gamma-tocotrienol and simvastatin. Mil Med. 184
(Suppl 1):S644–S651. 2019. View Article : Google Scholar
|
|
63
|
Anscher MS, Chang MG, Moghanaki D, Rosu M,
Mikkelsen RB, Holdford D, Skinner V, Grob BM, Sanyal A, Wang A and
Mukhopadhyay ND: A phase II study to prevent radiation-induced
rectal injury with lovastatin. Am J Clin Oncol. 41:544–548. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ostrau C, Hülsenbeck J, Herzog M, Schad A,
Torzewski M, Lackner KJ and Fritz G: Lovastatin attenuates ionizing
radiation-induced normal tissue damage in vivo. Radiother Oncol.
92:492–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ziegler V, Henninger C, Simiantonakis I,
Buchholzer M, Ahmadian MR, Budach W and Fritz G: Rho inhibition by
lovastatin affects apoptosis and DSB repair of primary human lung
cells in vitro and lung tissue in vivo following fractionated
irradiation. Cell Death Dis. 8:e29782017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bachelet JT, Granzotto A, Ferlazzo M,
Sonzogni L, Berthel E, Devic C and Foray N: First radiobiological
characterization of the McCune-Albright syndrome: Influence of the
ATM protein and effect of statins + bisphosphonates treatment. Int
J Radiat Biol. 97:317–328. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wedlake LJ, Silia F, Benton B, Lalji A,
Thomas K, Dearnaley DP, Blake P, Tait D, Khoo VS and Andreyev HJ:
Evaluating the efficacy of statins and ACE-inhibitors in reducing
gastrointestinal toxicity in patients receiving radiotherapy for
pelvic malignancies. Eur J Cancer. 48:2117–2124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cui M, Xiao H, Li Y, Zhang S, Dong J, Wang
B, Zhu C, Jiang M, Zhu T, He J, et al: Sexual dimorphism of gut
microbiota dictates therapeutics efficacy of radiation injuries.
Adv Sci (Weinh). 6:19010482019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang K, He X, Zhou Y, Gao L, Qi Z, Chen J
and Gao X: Atorvastatin ameliorates radiation-induced cardiac
fibrosis in rats. Radiat Res. 184:611–620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Do TM, Unis GD, Kattar N, Ananth A and
McCoul ED: Neuromodulators for atypical facial pain and neuralgias:
A systematic review and meta-analysis. Laryngoscope. 131:1235–1253.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Guéguen Y, Bontemps A and Ebrahimian TG:
Adaptive responses to low doses of radiation or chemicals: Their
cellular and molecular mechanisms. Cell Mol Life Sci. 76:1255–1273.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Di Stefano G, Maarbjerg S and Truini A:
Trigeminal neuralgia secondary to multiple sclerosis: From the
clinical picture to the treatment options. J Headache Pain.
20:202019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bal W, Łabuz-Roszak B, Tarnawski R and
Lasek-Bal A: Effectiveness and safety of CyberKnife radiosurgery in
treatment of trigeminalgia-experiences of Polish neurological and
oncological centres. Neurol Neurochir Pol. 54:28–32. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Khalil NY and Aldosari KF: Meloxicam.
Profiles Drug Subst Excip Relat Methodol. 45:159–197. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yamasaki MC, Roque-Torres GD, Peroni LV,
Nascimento EHL, Salmon B, Oliveira ML, Freitas DQ and
Correr-Sobrinho L: Does the administration of meloxicam before head
and neck radiotherapy reduce the risk of mandibular
osteoradionecrosis? An animal model study. Clin Oral Investig.
25:3739–3745. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yamasaki MC, Nejaim Y, Roque-Torres GD and
Freitas DQ: Meloxicam as a radiation-protective agent on mandibles
of irradiated rats. Braz Dent J. 28:249–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhou Y, Dong X, Xiu P, Wang X, Yang J, Li
L, Li Z, Sun P, Shi X and Zhong J: Meloxicam, a selective COX-2
inhibitor, mediates hypoxia-inducible factor-(HIF-) 1α signaling in
hepatocellular carcinoma. Oxid Med Cell Longev. 2020:70793082020.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Uehara Y, Murata Y, Shiga S and Hosoi Y:
NSAIDs diclofenac, indomethacin, and meloxicam highly upregulate
expression of ICAM-1 and COX-2 induced by X-irradiation in human
endothelial cells. Biochem Biophys Res Commun. 479:847–852. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang KF, Wang J, Guo J, Huang YY and
Huang TR: Metformin enhances radiosensitivity in hepatocellular
carcinoma by inhibition of specificity protein 1 and
epithelial-to-mesenchymal transition. J Cancer Res Ther.
15:1603–1610. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang J, Wang Y, Han J, Mei H, Yu D, Ding
Q, Zhang T, Wu G, Peng G and Lin Z: Metformin attenuates
radiation-induced pulmonary fibrosis in a murine model. Radiat Res.
188:105–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Da F, Guo J, Yao L, Gao Q, Jiao S, Miao X
and Liu J: Pretreatment with metformin protects mice from
whole-body irradiation. J Radiat Res. 62:618–625. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Adeberg S, Bernhardt D, Harrabi SB,
Nicolay NH, Hörner-Rieber J, König L, Repka M, Mohr A, Abdollahi A,
Weber KJ, et al: Metformin enhanced in vitro radiosensitivity
associates with G2/M cell cycle arrest and elevated
adenosine-5′-monophosphate-activated protein kinase levels in
glioblastoma. Radiol Oncol. 51:431–437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Nakayama A, Ninomiya I, Harada S, Tsukada
T, Okamoto K, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi
H, et al: Metformin inhibits the radiation-induced invasive
phenotype of esophageal squamous cell carcinoma. Int J Oncol.
49:1890–1898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Rezaei N, Neshasteh-Riz A, Mazaheri Z,
Koosha F and Hoormand M: The combination of metformin and
disulfiram-cu for effective radiosensitization on glioblastoma
cells. Cell J. 22:263–272. 2020.PubMed/NCBI
|
|
85
|
Kolivand S, Motevaseli E, Cheki M,
Mahmoudzadeh A, Shirazi A and Fait V: The anti-apoptotic mechanism
of metformin against apoptosis induced by ionizing radiation in
human peripheral blood mononuclear cells. Klin Onkol. 30:372–379.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Batinic-Haberle I, Tovmasyan A, Huang Z,
Duan W, Du L, Siamakpour-Reihani S, Cao Z, Sheng H, Spasojevic I
and Alvarez Secord A: H2O2-driven anticancer
activity of Mn porphyrins and the underlying molecular pathways.
Oxid Med Cell Longev. 2021:66537902021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Feliciano CP and Nagasaki Y: Oral
nanotherapeutics: Redox nanoparticles attenuate ultraviolet B
radiation-induced skin inflammatory disorders in Kud: Hr-hairless
mice. Biomaterials. 142:162–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang F, Gao P, Guo L, Meng P, Fan Y, Chen
Y, Lin Y, Guo G, Ding G and Wang H: Radio-protective effect and
mechanism of 4-Acetamido-2,2,6,6-tetramethylpiperidin-1-oxyl in
HUVEC cells. Environ Health Prev Med. 22:142017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Feliciano CP, Tsuboi K, Suzuki K, Kimura H
and Nagasaki Y: Long-term bioavailability of redox nanoparticles
effectively reduces organ dysfunctions and death in whole-body
irradiated mice. Biomaterials. 129:68–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liu Z, Lei X, Li X, Cai JM, Gao F and Yang
YY: Toll-like receptors and radiation protection. Eur Rev Med
Pharmacol Sci. 22:31–39. 2018.PubMed/NCBI
|
|
91
|
Chen Y, Xu Y, Du J, Guo J, Lei X, Cui J,
Liu C, Cheng Y, Li B, Gao F, et al: Radioprotective effects of
heat-killed mycobacterium tuberculosis in cultured cells and
radiosensitive tissues. Cell Physiol Biochem. 40:716–726. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Shi T, Li L, Zhou G, Wang C, Chen X, Zhang
R, Xu J, Lu X, Jiang H and Chen J: Toll-like receptor 5 agonist
CBLB502 induces radioprotective effects in vitro. Acta Biochim
Biophys Sin (Shanghai). 49:487–495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zheng L, Asprodites N, Keene AH, Rodriguez
P, Brown KD and Davila E: TLR9 engagement on CD4 T lymphocytes
represses gamma-radiation-induced apoptosis through activation of
checkpoint kinase response elements. Blood. 111:2704–2713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Liu C, Zhang C, Mitchel RE, Cui J, Lin J,
Yang Y, Liu X and Cai J: A critical role of toll-like receptor 4
(TLR4) and its' in vivo ligands in basal radio-resistance. Cell
Death Dis. 4:e6492013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Burdelya LG, Krivokrysenko VI, Tallant TC,
Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL,
Didonato JA, et al: An agonist of toll-like receptor 5 has
radioprotective activity in mouse and primate models. Science.
320:226–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Bai H, Sun F, Yang G, Wang L, Zhang Q,
Zhang Q, Zhan Y, Chen J, Yu M, Li C, et al: CBLB502, a Toll-like
receptor 5 agonist, offers protection against radiation-induced
male reproductive system damage in mice. Biol Reprod. 100:281–291.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Saha S, Bhanja P, Liu L, Alfieri AA, Yu D,
Kandimalla ER, Agrawal S and Guha C: TLR9 agonist protects mice
from radiation-induced gastrointestinal syndrome. PLoS One.
7:e293572012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Walshaw RC, Honeychurch J, Choudhury A and
Illidge TM: Toll-like receptor agonists and radiation therapy
combinations: An untapped opportunity to induce anticancer immunity
and improve tumor control. Int J Radiat Oncol Biol Phys. 108:27–37.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Schmitt H, Ulmschneider J, Billmeier U,
Vieth M, Scarozza P, Sonnewald S, Reid S, Atreya I, Rath T, Zundler
S, et al: The TLR9 agonist cobitolimod induces IL10-producing wound
healing macrophages and regulatory T cells in ulcerative colitis. J
Crohns Colitis. 14:508–524. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ogretmen B: Sphingolipid metabolism in
cancer signalling and therapy. Nat Rev Cancer. 18:33–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Li Y, Jiang X, Luo T, Xia J, Lee MJ,
Weichselbaum RR and Lin W: TLR3 agonist nanoscale coordination
polymer synergizes with immune checkpoint blockade for
immunotherapy of cancer. Biomaterials. 290:1218312022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang Y, Feng Z and Liu J, Li J, Su Q,
Zhang J, Huang P, Wang W and Liu J: Polarization of
tumor-associated macrophages by TLR7/8 conjugated radiosensitive
peptide hydrogel for overcoming tumor radioresistance. Bioact
Mater. 16:359–371. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wang H, Huang H and Ding SF:
Sphingosine-1-phosphate promotes the proliferation and attenuates
apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt
pathway. Cell Biol Int. 42:1492–1502. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Nitzsche A, Poittevin M, Benarab A, Bonnin
P, Faraco G, Uchida H, Favre J, Garcia-Bonilla L, Garcia MCL, Léger
PL, et al: Endothelial S1P1 signaling counteracts infarct expansion
in ischemic stroke. Circ Res. 128:363–382. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Zelinski MB, Murphy MK, Lawson MS,
Jurisicova A, Pau KY, Toscano NP, Jacob DS, Fanton JK, Casper RF,
Dertinger SD and Tilly JL: In vivo delivery of FTY720 prevents
radiation-induced ovarian failure and infertility in adult female
nonhuman primates. Fertil Steril. 95:1440–1445.e1-e7. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Guzel Y, Bildik G and Oktem O:
Sphingosine-1-phosphate protects human ovarian follicles from
apoptosis in vitro. Eur J Obstet Gynecol Reprod Biol. 222:19–24.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ghasemnezhad Targhi R and Saba V: Grape
seed extract alleviates radiation-induced damages in human blood
lymphocytes. Avicenna J Phytomed. 10:398–406. 2020.PubMed/NCBI
|
|
108
|
Ansari L, Banaei A, Dastranj L, Majdaeen
M, Vafapour H, Zamani H, Ataei G and Abedi-Firouzjah R: Evaluating
the radioprotective effect of single dose and daily oral
consumption of green tea, grape seed, and coffee bean extracts
against gamma irradiation. Appl Radiat Isot. 174:1097812021.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ghosh D, Pal S, Saha C, Chakrabarti AK,
Datta SC and Dey SK: Black tea extract: A supplementary antioxidant
in radiation-induced damage to DNA and normal lymphocytes. J
Environ Pathol Toxicol Oncol. 31:155–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ježovičová M, Koňariková K, Ďuračková Z,
Keresteš J, Králik G and Žitňanová I: Protective effects of black
tea extract against oxidative DNA damage in human lymphocytes. Mol
Med Rep. 13:1839–1844. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Shen N, Wang T, Gan Q, Liu S, Wang L and
Jin B: Plant flavonoids: Classification, distribution,
biosynthesis, and antioxidant activity. Food Chem. 383:1325312022.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li C, Yu M, Li S, Yang X, Qiao B, Shi S,
Zhao C and Fu Y: Valorization of Fig (Ficus carica L.) waste
leaves: HPLC-QTOF-MS/MS-DPPH system for online screening and
identification of antioxidant compounds. Plants (Basel).
10:25322021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kamran MZ, Ranjan A, Kaur N, Sur S and
Tandon V: Radioprotective agents: Strategies and translational
advances. Med Res Rev. 36:461–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Mortazavi SM, Rahimi S, Mosleh-Shirazi MA,
Arjomandi M, Soleimani A, Koohi Hossein-Abadi O, Haghani M and
Alavi M: A comparative study on the life-saving radioprotective
effects of vitamins A, E, C and over-the-counter multivitamins. J
Biomed Phys Eng. 5:59–66. 2015.PubMed/NCBI
|
|
115
|
Harapanhalli RS, Narra VR, Yaghmai V,
Azure MT, Goddu SM, Howell RW and Rao DV: Vitamins as
radioprotectors in vivo. II. Protection by vitamin A and soybean
oil against radiation damage caused by internal radionuclides.
Radiat Res. 139:115–122. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Safaei M, Jafarpour SM, Mohseni M,
Salimian M, Akbari H, Karami F, Aliasgharzadeh A and Farhood B:
Vitamins E and C prevent DNA double-strand breaks in peripheral
lymphocytes exposed to radiations from iodine-131. Indian J Nucl
Med. 33:20–24. 2018.PubMed/NCBI
|
|
117
|
Narra VR, Howell RW, Sastry KS and Rao DV:
Vitamin C as a radioprotector against iodine-131 in vivo. J Nucl
Med. 34:637–640. 1993.PubMed/NCBI
|
|
118
|
Srinivasan V and Weiss JF: Radioprotection
by vitamin E: Injectable vitamin E administered alone or with
WR-3689 enhances survival of irradiated mice. Int J Radiat Oncol
Biol Phys. 23:841–845. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Bagheri H, Salajegheh A, Javadi A, Amini
P, Shekarchi B, Shabeeb D, Eleojo Musa A and Najafi M:
Radioprotective effects of zinc and selenium on mice
spermatogenesis. J Biomed Phys Eng. 10:707–712. 2020.PubMed/NCBI
|
|
120
|
Liang S, Jin YX, Yuan B, Zhang JB and Kim
NH: Melatonin enhances the developmental competence of porcine
somatic cell nuclear transfer embryos by preventing DNA damage
induced by oxidative stress. Sci Rep. 7:111142017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Mao A, Guo H, Liu Y, Wang F, Tang J, Liao
S, Zhang Y, Sun C, Xia X and Zhang H: Exogenous melatonin modulates
carbon ion radiation-induced immune dysfunction in mice.
Toxicology. 417:35–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Shibai A, Satoh K, Kawada M, Kotani H,
Narumi I and Furusawa C: Complete genome sequence of a
radioresistant bacterial strain, Deinococcus grandis ATCC
43672. Microbiol Resour Announc. 8:e01226–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Lin SM, Baek CY, Jung JH, Kim WS, Song HY,
Lee JH, Ji HJ, Zhi Y, Kang BS, Bahn YS, et al: Antioxidant
activities of an exopolysaccharide (DeinoPol) produced by the
extreme radiation-resistant bacterium Deinococcus
radiodurans. Sci Rep. 10:552020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Riehl TE, Alvarado D, Ee X, Zuckerman A,
Foster L, Kapoor V, Thotala D, Ciorba MA and Stenson WF:
Lactobacillus rhamnosus GG protects the intestinal epithelium from
radiation injury through release of lipoteichoic acid, macrophage
activation and the migration of mesenchymal stem cells. Gut.
68:1003–1013. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Guo H, Chou WC, Lai Y, Liang K, Tam JW,
Brickey WJ, Chen L, Montgomery ND, Li X, Bohannon LM, et al:
Multi-omics analyses of radiation survivors identify
radioprotective microbes and metabolites. Science.
370:eaay90972020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Akeem S, Lukman O, Eltahir K, Fatai O,
Abiola B and Khadijat O: Bone marrow and peripheral blood cells
toxicity of a single 2.0 Gy Cobalt60 ionizing radiation:
An animal model. Ethiop J Health Sci. 29:195–202. 2019.PubMed/NCBI
|
|
127
|
Chin SP, Mohd-Shahrizal MY, Liyana MZ,
Then KY and Cheong SK: High dose of intravenous allogeneic
umbilical cord-derived mesenchymal stem cells (CLV-100) infusion
displays better immunomodulatory effect among healthy volunteers: A
phase 1 clinical study. Stem Cells Int. 2020:88770032020.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lykov AP, Bondarenko NA, Poveshchenko OV,
Kabakov AV, Surovtseva MA, Kim II, Kazakov OV, Poveshchenko AF and
Iankaĭte EV: Therapeutic potential of a biomedical cellular product
in rats with lower limb ischaemia. Angiol Sosud Khir. 26:37–43.
2020.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
129
|
DiCarlo AL, Horta ZP, Aldrich JT,
Jakubowski AA, Skinner WK and Case CM Jr: Use of growth factors and
other cytokines for treatment of injuries during a radiation public
health emergency. Radiat Res. 192:99–120. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Pourgholaminejad A, Aghdami N, Baharvand H
and Moazzeni SM: The effect of pro-inflammatory cytokines on
immunophenotype, differentiation capacity and immunomodulatory
functions of human mesenchymal stem cells. Cytokine. 85:51–60.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Qiao S, Ren H, Shi Y and Liu W: Allogeneic
compact bone-derived mesenchymal stem cell transplantation
increases survival of mice exposed to lethal total body
irradiation: A potential immunological mechanism. Chin Med J
(Engl). 127:475–482. 2014.PubMed/NCBI
|
|
132
|
Nevens F and van der Merwe S: Mesenchymal
stem cell transplantation in liver diseases. Semin Liver Dis.
42:283–292. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Liu FD, Tam K, Pishesha N, Poon Z and Van
Vliet KJ: Improving hematopoietic recovery through modeling and
modulation of the mesenchymal stromal cell secretome. Stem Cell Res
Ther. 9:2682018. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Court AC, Le-Gatt A, Luz-Crawford P, Parra
E, Aliaga-Tobar V, Bátiz LF, Contreras RA, Ortúzar MI, Kurte M,
Elizondo-Vega R, et al: Mitochondrial transfer from MSCs to T cells
induces Treg differentiation and restricts inflammatory response.
EMBO Rep. 21:e480522020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Haarer J, Johnson CL, Soeder Y and Dahlke
MH: Caveats of mesenchymal stem cell therapy in solid organ
transplantation. Transpl Int. 28:1–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Jo H, Brito S, Kwak BM, Park S, Lee MG and
Bin BH: Applications of mesenchymal stem cells in skin regeneration
and rejuvenation. Int J Mol Sci. 2:24102021. View Article : Google Scholar
|
|
137
|
Huang YZ, Gou M, Da LC, Zhang WQ and Xie
HQ: Mesenchymal stem cells for chronic wound healing: Current
status of preclinical and clinical studies. Tissue Eng Part B Rev.
26:555–570. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Benderitter M, Herrera-Reyes E and Tamarat
R: Mesenchymal stromal cells in the regeneration of
radiation-induced organ sequelae: Will they make the difference? J
Radiol Prot. 42:2022. View Article : Google Scholar
|
|
139
|
Sun J, Zhang Y, Song X, Zhu J and Zhu Q:
The healing effects of conditioned medium derived from mesenchymal
stem cells on radiation-induced skin wounds in rats. Cell
Transplant. 28:105–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Dao A, McDonald MM, Savage PB, Little DG
and Schindeler A: Preventing osteolytic lesions and osteomyelitis
in multiple myeloma. J Bone Oncol. 37:1004602022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Jiang X, Yang J, Liu F, Tao J, Xu J and
Zhang M: Embryonic stem cell-derived mesenchymal stem cells
alleviate skeletal muscle injury induced by acute compartment
syndrome. Stem Cell Res Ther. 13:3132022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Rahyussalim AJ, Nasser MK, Al As'ady FM
and Kurniawati T: Umbilical cord-derived mesenchymal stem cells
implantation on Hemivertebra defect with three-year follow-up:
Biological approach in congenital scoliosis treatment-a case
report. Int J Surg Case Rep. 99:1076022022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Fujii S and Miura Y: Immunomodulatory and
regenerative effects of MSC-derived extracellular vesicles to treat
acute GVHD. Stem Cells. 40:977–990. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Gong W, Guo M, Han Z, Wang Y, Yang P, Xu
C, Wang Q, Du L, Li Q, Zhao H, et al: Mesenchymal stem cells
stimulate intestinal stem cells to repair radiation-induced
intestinal injury. Cell Death Dis. 7:e23872016. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Hou G, Li J, Liu W, Wei J, Xin Y and Jiang
X: Mesenchymal stem cells in radiation-induced lung injury: From
mechanisms to therapeutic potential. Front Cell Dev Biol.
10:11003052022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Leclerc T, Thepenier C, Jault P, Bey E,
Peltzer J, Trouillas M, Duhamel P, Bargues L, Prat M, Bonderriter M
and Lataillade JJ: Cell therapy of burns. Cell Prolif. 44 (Suppl
1):S48–S54. 2011. View Article : Google Scholar
|
|
147
|
Maleki M, Ghanbarvand F, Reza Behvarz M,
Ejtemaei M and Ghadirkhomi E: Comparison of mesenchymal stem cell
markers in multiple human adult stem cells. Int J Stem Cells.
7:118–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Lin H, Ouyang H, Zhu J, Huang S, Liu Z,
Chen S, Cao G, Li G, Signer RA, Xu Y, et al: Lens regeneration
using endogenous stem cells with gain of visual function. Nature.
531:323–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Xing Y, Li B, He J and Hua H: Labial gland
mesenchymal stem cell derived exosomes-mediated miRNA-125b
attenuates experimental Sjogren's syndrome by targeting PRDM1 and
suppressing plasma cells. Front Immunol. 13:8710962022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Sun T, Liu S, Yang G, Zhu R, Li Z, Yao G,
Chen H and Sun L: Mesenchymal stem cell transplantation alleviates
Sjögren's syndrome symptoms by modulating Tim-3 expression. Int
Immunopharmacol. 111:1091522022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Jansson PM, Lynggaard CD, Carlander AF,
Jensen SB, Follin B, Hoeeg C, Kousholt BS, Larsen RT, Grønhøj C,
Jakobsen KK, et al: Mesenchymal stromal/stem cell therapy for
radiation-induced salivary gland hypofunction in animal models: A
protocol for a systematic review and meta-analysis. Syst Rev.
11:722022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Lynggaard CD, Grønhøj C, Jensen SB,
Christensen R, Specht L, Andersen E, Andersen TT, Ciochon UM,
Rathje GS, Hansen AE, et al: Long-term safety of treatment with
autologous mesenchymal stem cells in patients with
radiation-induced xerostomia: Primary results of the MESRIX phase
I/II randomized trial. Clin Cancer Res. 28:2890–2897. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hérodin F and Drouet M: Cytokine-based
treatment of accidentally irradiated victims and new approaches.
Exp Hematol. 33:1071–1080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Peng Y, Wu S, Tang Q, Li S and Peng C:
KGF-1 accelerates wound contraction through the TGF-β1/Smad
signaling pathway in a double-paracrine manner. J Biol Chem.
294:8361–8370. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Chen Y, Rubin P, Williams J, Hernady E,
Smudzin T and Okunieff P: Circulating IL-6 as a predictor of
radiation pneumonitis. Int J Radiat Oncol Biol Phys. 49:641–648.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Damm R, Pech M, Haag F, Cavalli P,
Gylstorff S, Omari J, Seidensticker R, Ricke J, Seidensticker M and
Relja B: TNF-α indicates radiation-induced liver injury after
interstitial high dose-rate brachytherapy. In Vivo. 36:2265–2274.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wang J, Xu Z, Wang Z, Du G and Lun L:
Corrigendum to ‘TGF-beta signaling in cancer radiotherapy’
[Cytokine 148 (2021) 155709]. Cytokine. 149:1557532022. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Lee S and Ki CS: Inflammatory responses of
macrophage-like RAW264.7 cells in a 3D hydrogel matrix to
ultrasonicated schizophyllan. Carbohydr Polym. 229:1155552020.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Moorlag SJCFM, Khan N, Novakovic B,
Kaufmann E, Jansen T, van Crevel R, Divangahi M and Netea MG:
β-Glucan induces protective trained immunity against mycobacterium
tuberculosis infection: A key role for IL-1. Cell Rep.
31:1076342020. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Song JY, Han SK, Bae KG, Lim DS, Son SJ,
Jung IS, Yi SY and Yun YS: Radioprotective effects of ginsan, an
immunomodulator. Radiat Res. 159:768–774. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wu T, Liu W, Fan T, Zhong H, Zhou H, Guo W
and Zhu X: 5-Androstenediol prevents radiation injury in mice by
promoting NF-κB signaling and inhibiting AIM2 inflammasome
activation. Biomed Pharmacother. 121:1095972020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Everett WH and Curiel DT: Gene therapy for
radioprotection. Cancer Gene Ther. 22:172–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Khalifa J, François S, Rancoule C,
Riccobono D, Magné N, Drouet M and Chargari C: Gene therapy and
cell therapy for the management of radiation damages to healthy
tissues: Rationale and early results. Cancer Radiother. 23:449–465.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Maier P, Veldwijk MR and Wenz F:
Radioprotective gene therapy. Expert Opin Biol Ther. 11:1135–1151.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Zhang Z, Lang J, Cao Z, Li R, Wang X and
Wang W: Radiation-induced SOD2 overexpression sensitizes colorectal
cancer to radiation while protecting normal tissue. Oncotarget.
8:7791–7800. 2017. View Article : Google Scholar : PubMed/NCBI
|
